FDA grants orphan drug designation to Reneo Pharmaceuticals for REN001 to treat fatty acid oxidation disorders

Image: The FDA has granted orphan drug designation to Reneo Pharmaceuticals for REN001 to treat fatty acid oxidation disorders. Photo: courtesy of moritz320 from Pixabay.